Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: dyspnea on exertion major surgical or invasive procedure: mitral valve repair (p2 resection and 28mm band) history of present illness: 56 y/o male w/ mitral regurgitation followed by serial echocardiograms. he has noticed a decrease in his activity tolerance along with dyspnea on exertion. a recent echo revealed 4+ mitral regurgitation and was referred for surgical management. past medical history: mitral regurgitation, hyperlipidemia, asthma, seasonal allergies social history: denies tobacco use. admits to 2-3 beers/wk. administrator for school. family history: father w/ mi and cabg in his 60's. physical exam: vs: 73 18 130/80 5'6" 135# gen: wdwn male in nad skin: unremarkable heent: eomi, perrl, ncat neck: supple, from, -jvd, -carotid dz chest: ctab heart: rrr, harsh syst. murmur abd: soft, nt/nt +bs ext: warm, well-perfused -edema neuro: a&o x 3, mae pertinent results: echo: pre-bypass: the left atrium is moderately dilated. no spontaneous echo contrast or thrombus is seen in the body of the left atrium or left atrial appendage. no spontaneous echo contrast or thrombus is seen in the body of the right atrium or the right atrial appendage. no atrial septal defect is seen by 2d or color doppler. the estimated right atrial pressure is 0-5 mmhg. left ventricular wall thicknesses and cavity size are normal. overall left ventricular systolic function is normal (lvef>55%). right ventricular chamber size and free wall motion are normal. there are simple atheroma in the descending thoracic aorta. there are three aortic valve leaflets. the aortic valve leaflets are mildly thickened. there is no aortic valve stenosis. no aortic regurgitation is seen. the mitral valve leaflets are moderately thickened. the mitral valve leaflets are elongated. there is moderate/severe mitral valve prolapse. there is partial mitral leaflet flail. severe (4+) mitral regurgitation is seen. due to the eccentric nature of the regurgitant jet, its severity may be significantly underestimated (coanda effect). there is no pericardial effusion. 01:40pm blood wbc-11.8*# rbc-2.52*# hgb-8.4*# hct-23.6*# mcv-94 mch-33.3* mchc-35.7* rdw-12.3 plt ct-175 05:25am blood wbc-9.2 rbc-2.71* hgb-9.0* hct-25.5* mcv-94 mch-33.1* mchc-35.1* rdw-13.0 plt ct-126* 01:40pm blood pt-15.8* ptt-35.6* inr(pt)-1.4* 05:25am blood glucose-118* urean-14 creat-0.9 na-136 k-4.5 cl-105 hco3-28 angap-8 brief hospital course: mr. was a same day admit after undergoing pre-operative work-up as an outpatient. on day of admission he was brought to the operating room where he underwent a mitral valve repair. please see operative report for surgical details. following surgery he was transferred to the cvicu for invasive management in stable condition. later on op day he was weaned from sedation, awoke neurologically intact and extubated. on post-op day one his chest tubes were removed and he was transferred to the telemetry floor for further care. he was also started on beta blockers and diuretics and gently diuresed towards his pre-op weight. epicardial pacing wires were removed on post-op day three. he continued to progress quite well post-op and worked with physical therapy for strength and mobility. on post-op day 5 he was discharged home with vna services and the appropriate follow-up appointments. medications on admission: zocor 40mg qd, mvi, zyrtec d discharge medications: 1. metoprolol tartrate 25 mg tablet sig: 0.5 tablet po bid (2 times a day). disp:*30 tablet(s)* refills:*1* 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*1* 4. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*40 tablet(s)* refills:*0* 5. simvastatin 40 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 6. tamsulosin 0.4 mg capsule, sust. release 24 hr sig: one (1) capsule, sust. release 24 hr po hs (at bedtime). disp:*30 capsule, sust. release 24 hr(s)* refills:*0* 7. furosemide 40 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*2* 8. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po once a day. disp:*30 tab sust.rel. particle/crystal(s)* refills:*2* 9. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* discharge disposition: home with service facility: hospice and vna discharge diagnosis: mitral regurgitation s/p mitral valve repair pmh: hyperlipidemia, asthma, seasonal allergies discharge condition: good discharge instructions: 1)shower daily. wash incisions with soap and water. pat dry only. please do not apply lotions or creams to surgical incisions. 2)no driving for at least one month. 3)no lifting more than 10lbs for at least 10 weeks. 4)call cardiac surgeon if there is any concern for sternal wound infection. followup instructions: dr. in 4 weeks dr. in weeks dr. in weeks procedure: extracorporeal circulation auxiliary to open heart surgery open heart valvuloplasty of mitral valve without replacement diagnoses: mitral valve disorders asthma, unspecified type, unspecified other and unspecified hyperlipidemia 

Answer: The patient is high likely exposed to